Effects of the Cannabinoid-1 Receptor Blocker Rimonabant on Weight Reduction and Cardiovascular Risk Factors in Overweight Patients: 1-Year Experience From the RIO-Europe Study

✍ Scribed by L.F. Van Gaal; A.M. Rissanen; A.J. Scheen; O. Ziegler; S. Rossner

• Book ID: 113415162
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 35 KB
• Volume: 14
• Category: Article
• ISSN: 1062-1458
• DOI: 10.1016/j.accreview.2005.06.021